News | July 21, 2014

Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386 DUBLIN & LEXINGTON, Mass.–July 21, 2014– Jazz Pharmaceuticals plc (NASDAQ: JAZZ) and Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced the...

News | July 22, 2014

LifePoint Hospitals’ Fauquier Health, Selects TigerText as its Facility-Wide Secure Messaging Solution Fauquier Health chooses TigerText’s secure messaging platform to streamline internal communication and provide more efficient care to patients. SANTA...

News | July 30, 2014

Durata Therapeutics Enters Into an Exclusive License and Supply Agreement With Angelini to Commercialize Dalbavancin in Certain European Territories, Russia and Turkey Approximately $80M in Upfront and Milestone Payments CHICAGO, July 30, 2014 (GLOBE NEWSWIRE) —...

News | July 31, 2014

New Data on Chimerix’s Brincidofovir Supports Safety and Antiviral Activity Against Multiple Life-Threatening DNA Viruses in Organ Transplant Recipients Three Abstracts Presented at 2014 World Transplant Congress DURHAM, N.C., July 31, 2014 (GLOBE NEWSWIRE)...

News | August 5, 2014

Oxford Immunotec Announces Purchase Of Assets Of Boulder Diagnostics Inc. OXFORD, United Kingdom and MARLBOROUGH, Mass., August 5, 2014 (GLOBE NEWSWIRE) – Oxford Immunotec Global PLC (NASDAQ: OXFD), a global, commercial-stage diagnostics company committed to...